• NF-κB/Apaf1/Caspase-9 Axis Drives Inflammation in Septic AKI

  2026-05-19

  This study identifies the sequential activation of the NF-κB/Apaf1/caspase-9 pathway as a central driver of tubular inflammation and apoptosis in septic acute kidney injury (AKI). By demonstrating that suppression of this axis restores autophagy and limits renal damage, the research highlights a promising mechanistic target for intervention in sepsis-associated AKI.

• MYC2-LBD40/42-CRL3BPM4 Module Tunes Tomato Botrytis Defense

  2026-05-18

  The referenced study uncovers a regulatory module in tomato involving MYC2, LBD40/42, and CRL3BPM4 that finely balances defense against Botrytis cinerea and growth. These findings highlight the molecular interplay between immune activation and transcriptional repression, providing potential genetic targets for crop improvement.

• Mechanisms of CARMIL’s Membrane-Binding Domain in Actin Regu

  2026-05-18

  This study elucidates how the membrane-binding (MB) domain of CARMIL orchestrates actin assembly at the plasma membrane through dynamic regulation of capping protein (CP) activity. The findings resolve key gaps in our understanding of membrane-associated actin remodeling and highlight the MB domain’s multifaceted control over actin network dynamics.

• Oligomycin A: Precision Mitochondrial ATP Synthase Inhibitor

  2026-05-17

  Oligomycin A empowers researchers to dissect mitochondrial bioenergetics and cancer metabolism with unmatched specificity. This guide details actionable experimental workflows, troubleshooting, and strategic insights, leveraging the latest findings and best practices for robust, reproducible results.

• H 89 2HCl: Applied PKA Inhibition for cAMP Pathway Dissectio

  2026-05-16

  H 89 2HCl empowers researchers to dissect cAMP/PKA signaling with exceptional specificity, making it a cornerstone tool for unraveling protein phosphorylation dynamics and cellular differentiation. This guide delivers actionable workflow enhancements, troubleshooting strategies, and real-world protocol parameters—bridging foundational research with advanced applications in neurobiology and bone metabolism.

• DAPI (hydrochloride): Mechanistic Insights and Assay Precisi

  2026-05-15

  Discover the unique mechanistic action of DAPI (hydrochloride), a DNA-specific fluorescent probe, and learn how its molecular specificity advances precision chromosome staining and cell cycle analysis. This article delivers a deeper technical perspective and practical assay recommendations for advanced researchers.

• GANT61: GLI Inhibitor Workflows for Tumor Growth Suppression

  2026-05-15

  GANT61 empowers cancer research by selectively inhibiting GLI-mediated transcription, offering robust protocols for dissecting tumor immune evasion and overcoming immunotherapeutic resistance. Its evidence-backed application in both in vitro and in vivo models makes it a cornerstone for Hedgehog pathway-targeted studies.

• GANT61 in Cancer Research: Precision GLI Inhibition and Tran

  2026-05-14

  Explore how GANT61, a selective GLI inhibitor, advances cancer research by targeting tumor immune evasion at the transcriptional level. This article uniquely details the mechanistic insights and protocol parameters that set GANT61 apart in translational oncology.

• Toremifene vs Tamoxifen: Evidence from Advanced Breast Cance

  2026-05-14

  This Cochrane review rigorously compares the efficacy and safety of toremifene and tamoxifen as selective estrogen receptor modulators in advanced breast cancer. The study's systematic approach offers clarity on outcomes relevant for estrogen receptor pathway research, with implications for translational studies in oncology and endocrine modulation.

• Spiroplasma eriocheiris Entry: Clathrin Endocytosis in Droso

  2026-05-13

  This study elucidates the cellular entry mechanisms of Spiroplasma eriocheiris in Drosophila Schneider 2 cells, demonstrating reliance on clathrin-mediated endocytosis and macropinocytosis. The work provides a robust infection model for invertebrate host-pathogen interactions and highlights assay strategies for dissecting endocytic pathways.

• Toremifene in Breast Cancer: 20 Years of Clinical Insights

  2026-05-13

  This review synthesizes two decades of data evaluating toremifene, a selective estrogen receptor modulator, for estrogen receptor-positive breast cancer. It highlights the mechanistic rationale, comparative efficacy, and nuanced clinical considerations that guide individualized endocrine therapy, providing a foundation for biomarker-driven treatment strategies.

• Necrosulfonamide: Precision MLKL Inhibition in Necroptosis A

  2026-05-12

  Necrosulfonamide (NSA) elevates necroptosis assay accuracy by selectively targeting MLKL translocation in programmed cell death research. Its nanomolar potency and workflow reliability make it indispensable for dissecting necroptotic mechanisms in cardiovascular, cancer, and neurodegenerative models.

• Defining SPEN–XIST A-Repeat Interactions in X Chromosome Ina

  2026-05-12

  This study delineates the protein and RNA features essential for SPEN's high-affinity binding to the XIST A-repeat, a key step in initiating X chromosome inactivation (XCI) in mammals. Through domain dissection and RNA structural analysis, the authors reveal how specific RNA motifs and SPEN domains cooperate to achieve selective recognition, advancing understanding of epigenetic silencing mechanisms.

• PDK4-IN-1 Hydrochloride: Advancing PDH Activation in Disease

  2026-05-11

  Explore how PDK4-IN-1 hydrochloride, a selective pyruvate dehydrogenase kinase 4 inhibitor, enables next-generation modulation of mitochondrial energy metabolism. This article offers advanced insight into assay design, translational impact, and practical applications distinct from existing guides.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-05-11

  The referenced study reveals that naturally occurring angiotensin peptides, particularly N-terminally truncated forms like Angiotensin III, significantly increase SARS-CoV-2 spike protein binding to the AXL receptor. These findings suggest a new mechanistic link between the renin-angiotensin system and viral entry, potentially informing both cardiovascular and infectious disease research.

406 records 8/28 page Previous Next First page 上5页 678910 下5页 Last page